Notch transactivates Rheb to maintain the multipotency of TSC-null cells
Male
0301 basic medicine
Lung Neoplasms
Science
Angiomyolipoma
610
Mice, Transgenic
Mice, SCID
Article
Tuberous Sclerosis Complex 1 Protein
03 medical and health sciences
Tuberous Sclerosis
Tuberous Sclerosis Complex 2 Protein
Animals
Humans
Lymphangioleiomyomatosis
Receptor, Notch1
Promoter Regions, Genetic
0303 health sciences
Tumor Suppressor Proteins
Q
Cell Differentiation
Xenograft Model Antitumor Assays
Neural Crest
Transcription Factor HES-1
Female
Ras Homolog Enriched in Brain Protein
DOI:
10.1038/s41467-017-01845-1
Publication Date:
2017-11-23T11:28:45Z
AUTHORS (17)
ABSTRACT
AbstractDifferentiation abnormalities are a hallmark of tuberous sclerosis complex (TSC) manifestations; however, the genesis of these abnormalities remains unclear. Here we report on mechanisms controlling the multi-lineage, early neuronal progenitor and neural stem-like cell characteristics of lymphangioleiomyomatosis (LAM) and angiomyolipoma cells. These mechanisms include the activation of a previously unreported Rheb-Notch-Rheb regulatory loop, in which the cyclic binding of Notch1 to the Notch-responsive elements (NREs) on the Rheb promoter is a key event. This binding induces the transactivation of Rheb. The identified NRE2 and NRE3 on the Rheb promoter are important to Notch-dependent promoter activity. Notch cooperates with Rheb to block cell differentiation via similar mechanisms in mouse models of TSC. Cell-specific loss of Tsc1 within nestin-expressing cells in adult mice leads to the formation of kidney cysts, renal intraepithelial neoplasia, and invasive papillary renal carcinoma.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (67)
CITATIONS (21)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....